Disease modification upon 2 weeks of tofacitinib treatment in a mouse model of chronic epilepsy | Science Translational Medicine


Brief administration of tofacitinib enduringly suppresses seizures, restores cognition, and dampens astrogliosis in a mouse model of chronic epilepsy.

Continue Reading